A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancers

Background: Bevacizumab has demonstrated antitumor activity in multiple diseases. This phase II study was undertaken to determine the effects of adding bevacizumab to a regimen of docetaxel and oxaliplatin in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction. Patients...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: El-Rayes, B. F., Zalupski, M., Bekai-Saab, T., Heilbrun, L. K., Hammad, N., Patel, B., Urba, S., Shields, A. F., Vaishampayan, U., Dawson, S., Almhanna, K., Smith, D., Philip, P. A.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2010
Teme:
Original Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2980934/
https://ncbi.nlm.nih.gov/pubmed/20332133
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdq065
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki